{
  "combination": {
    "prompt": "direct_mcode_evidence_based",
    "model": "deepseek-coder"
  },
  "success": true,
  "cv_average_score": 1.0,
  "cv_std_score": 0.0,
  "fold_scores": [
    1.0,
    1.0
  ],
  "cv_folds": 3,
  "total_trials": 2,
  "total_elements": 48,
  "errors": [
    "DeepSeek response contains truncated JSON (missing closing brace): {\n    \"mcode_mappings\": [\n        {\n            \"element_type\": \"CancerCondition\",\n            \"code\": \"C4872\",\n            \"display\": \"Breast Cancer\",\n            \"system\": \"NCI Thesaurus\",\n         ..."
  ],
  "timestamp": "2025-09-19T20:36:57.645975",
  "metrics": {
    "precision": 1.0,
    "recall": 1.0,
    "f1_score": 1.0
  },
  "predicted_mcode": [
    {
      "element_type": "ResearchStudy",
      "code": "SINGLE_GROUP",
      "display": "Single Group Assignment",
      "system": "http://hl7.org/fhir/research-study-classification",
      "confidence_score": 1.0,
      "evidence_text": "\"interventionModel\": \"SINGLE_GROUP\""
    },
    {
      "element_type": "ResearchStudy",
      "code": "NONE",
      "display": "No Masking",
      "system": "http://hl7.org/fhir/masking-level",
      "confidence_score": 1.0,
      "evidence_text": "\"masking\": \"NONE\""
    },
    {
      "element_type": "ResearchStudy",
      "code": "OTHER",
      "display": "Other",
      "system": "http://hl7.org/fhir/research-study-prim-purpose-type",
      "confidence_score": 1.0,
      "evidence_text": "\"primaryPurpose\": \"OTHER\""
    },
    {
      "element_type": "CancerCondition",
      "code": "254837009",
      "display": "Malignant neoplasm of breast",
      "system": "SNOMED CT",
      "confidence_score": 1.0,
      "evidence_text": "Breast Cancer"
    },
    {
      "element_type": "CancerCondition",
      "code": "254837009",
      "display": "Infiltrating duct carcinoma of breast",
      "system": "SNOMED CT",
      "confidence_score": 1.0,
      "evidence_text": "Histologic diagnosis of invasive breast cancer or ductal carcinoma in situ."
    },
    {
      "element_type": "CancerCondition",
      "code": "86049000",
      "display": "Carcinoma in situ of breast",
      "system": "SNOMED CT",
      "confidence_score": 1.0,
      "evidence_text": "Histologic diagnosis of invasive breast cancer or ductal carcinoma in situ."
    },
    {
      "element_type": "TumorSize",
      "code": "LP212175-6",
      "display": "Tumor size",
      "system": "LOINC",
      "confidence_score": 1.0,
      "evidence_text": "Tumor size at least 1 cm in diameter as visualized on mammogram or US."
    },
    {
      "element_type": "CancerRelatedMedication",
      "code": "C945",
      "display": "Neoadjuvant chemotherapy",
      "system": "NCI Thesaurus",
      "confidence_score": 1.0,
      "evidence_text": "Patients who have received neoadjuvant chemotherapy for their current diagnosis."
    },
    {
      "element_type": "ResearchStudy",
      "code": "LA33-6",
      "display": "Yes",
      "system": "LOINC",
      "confidence_score": 1.0,
      "evidence_text": "Ability to voluntarily provide informed consent to participate prior to any study-related assessments/procedures being conducted."
    },
    {
      "element_type": "ResearchStudy",
      "code": "LA33-6",
      "display": "Yes",
      "system": "LOINC",
      "confidence_score": 1.0,
      "evidence_text": "A staging, pre-operative breast MRI is considered to be clinically indicated."
    },
    {
      "element_type": "ResearchStudy",
      "code": "research-study",
      "display": "Research Study",
      "system": "http://hl7.org/fhir/resource-types",
      "confidence_score": 1.0,
      "evidence_text": "The purpose of this study is to determine whether a supine breast MRI obtained with a second intravenous injection of gadolinium contrast immediately after a standard clinical prone breast MRI will provide sufficient tumor visualization to allow a Radiologist to define and outline the tumor edges (\"segment\" the tumor)."
    },
    {
      "element_type": "ResearchStudy",
      "code": "research-study",
      "display": "Research Study",
      "system": "http://hl7.org/fhir/resource-types",
      "confidence_score": 1.0,
      "evidence_text": "The clinical pre-operative breast MRI exam will be obtained in the prone position with intravenous (IV) Gadolinium (Gd) contrast injection per standard of care clinical protocol."
    },
    {
      "element_type": "ResearchStudy",
      "code": "research-study",
      "display": "Research Study",
      "system": "http://hl7.org/fhir/resource-types",
      "confidence_score": 1.0,
      "evidence_text": "After completion of the standard clinical prone breast MRI, the participant will be re-positioned and the investigative supine breast MRI protocol with a second dose of IV Gd will be obtained."
    },
    {
      "element_type": "ResearchStudy",
      "code": "research-study",
      "display": "Research Study",
      "system": "http://hl7.org/fhir/resource-types",
      "confidence_score": 1.0,
      "evidence_text": "A second dose of contrast equal to the first dose will be given, and additional images will be obtained in the supine position."
    },
    {
      "element_type": "ResearchStudy",
      "code": "research-study",
      "display": "Research Study",
      "system": "http://hl7.org/fhir/resource-types",
      "confidence_score": 1.0,
      "evidence_text": "Subtraction images will be generated for both the prone and the supine sequences."
    },
    {
      "element_type": "ResearchStudy",
      "code": "research-study",
      "display": "Research Study",
      "system": "http://hl7.org/fhir/resource-types",
      "confidence_score": 1.0,
      "evidence_text": "It is hypothesized that the second contrast injection will generate tumor-to-fibroglandular contrast differences such that supine subtraction images will allow visualization and segmentation of the tumor equal to prone segmentation images."
    },
    {
      "element_type": "ResearchStudy",
      "code": "research-study",
      "display": "Research Study",
      "system": "http://hl7.org/fhir/resource-types",
      "confidence_score": 1.0,
      "evidence_text": "It is expected that the addition of a second injection of contrast will improve the ability to visualize and accurately segment the supine post-Gd images."
    },
    {
      "element_type": "ResearchStudy",
      "code": "research-study",
      "display": "Research Study",
      "system": "http://hl7.org/fhir/resource-types",
      "confidence_score": 1.0,
      "evidence_text": "While the total dose of gadolinium delivered in two injections is twice the amount normally given during a clinical prone breast MRI, this total dose is equal to that administered for other clinical MRI studies such as cardiac MRI."
    },
    {
      "element_type": "ResearchStudy",
      "code": "research-study",
      "display": "Research Study",
      "system": "http://hl7.org/fhir/resource-types",
      "confidence_score": 1.0,
      "evidence_text": "No additional imaging or testing will be required for this research study following the standard clinical MRI."
    },
    {
      "element_type": "ResearchStudy",
      "code": "research-study",
      "display": "Clinical Trial",
      "system": "http://hl7.org/fhir/resource-types",
      "confidence_score": 1.0,
      "evidence_text": "briefTitle: 21DIF039: Prone to Supine Breast MRI II, P2S2 Breast MRI Trial"
    },
    {
      "element_type": "ResearchStudy",
      "code": "NCT05131607",
      "display": "NCT05131607",
      "system": "http://clinicaltrials.gov",
      "confidence_score": 1.0,
      "evidence_text": "nctId: NCT05131607"
    },
    {
      "element_type": "ResearchStudy",
      "code": "randomized",
      "display": "Randomized allocation",
      "system": "http://hl7.org/fhir/research-study-classification",
      "confidence_score": 1.0,
      "evidence_text": "\"allocation\": \"RANDOMIZED\""
    },
    {
      "element_type": "ResearchStudy",
      "code": "parallel",
      "display": "Parallel assignment",
      "system": "http://hl7.org/fhir/research-study-classification",
      "confidence_score": 1.0,
      "evidence_text": "\"interventionModel\": \"PARALLEL\""
    },
    {
      "element_type": "ResearchStudy",
      "code": "prevention",
      "display": "Prevention",
      "system": "http://hl7.org/fhir/research-study-classification",
      "confidence_score": 1.0,
      "evidence_text": "\"primaryPurpose\": \"PREVENTION\""
    },
    {
      "element_type": "ResearchStudy",
      "code": "double-blind",
      "display": "Double blind",
      "system": "http://hl7.org/fhir/research-study-classification",
      "confidence_score": 1.0,
      "evidence_text": "\"masking\": \"DOUBLE\""
    },
    {
      "element_type": "CancerCondition",
      "code": "254837009",
      "display": "Malignant neoplasm of breast",
      "system": "SNOMED CT",
      "confidence_score": 1.0,
      "evidence_text": "Breast Cancer"
    },
    {
      "element_type": "CancerCondition",
      "code": "254837009",
      "display": "Malignant neoplasm of breast",
      "system": "SNOMED CT",
      "confidence_score": 1.0,
      "evidence_text": "breast cancer patient"
    },
    {
      "element_type": "CancerRelatedMedicationAdministration",
      "code": "367336001",
      "display": "Chemotherapy",
      "system": "SNOMED CT",
      "confidence_score": 1.0,
      "evidence_text": "treated with adjuvant chemotherapy"
    },
    {
      "element_type": "ResearchStudy",
      "code": "clinical-trial",
      "display": "Clinical trial eligibility criteria",
      "system": "mCODE",
      "confidence_score": 1.0,
      "evidence_text": "Eligibility Criteria: Inclusion Criteria:"
    },
    {
      "element_type": "ResearchStudy",
      "code": "minimum-age",
      "display": "Minimum age requirement",
      "system": "mCODE",
      "confidence_score": 1.0,
      "evidence_text": "minimumAge: 18 Years"
    },
    {
      "element_type": "ResearchStudy",
      "code": "healthy-volunteers",
      "display": "Healthy volunteers excluded",
      "system": "mCODE",
      "confidence_score": 1.0,
      "evidence_text": "healthyVolunteers: False"
    },
    {
      "element_type": "CancerCondition",
      "code": "C4872",
      "display": "Early Breast Cancer",
      "system": "NCI Thesaurus",
      "confidence_score": 1.0,
      "evidence_text": "early breast cancer"
    },
    {
      "element_type": "CancerRelatedMedication",
      "code": "C1326",
      "display": "Doxorubicin",
      "system": "NCI Thesaurus",
      "confidence_score": 1.0,
      "evidence_text": "adriamycin"
    },
    {
      "element_type": "CancerRelatedMedication",
      "code": "C405",
      "display": "Cyclophosphamide",
      "system": "NCI Thesaurus",
      "confidence_score": 1.0,
      "evidence_text": "cyclophosphamide"
    },
    {
      "element_type": "CancerRelatedMedication",
      "code": "C509",
      "display": "Fluorouracil",
      "system": "NCI Thesaurus",
      "confidence_score": 1.0,
      "evidence_text": "5- fluorouracil"
    },
    {
      "element_type": "CancerRelatedMedication",
      "code": "C945",
      "display": "Honey",
      "system": "NCI Thesaurus",
      "confidence_score": 1.0,
      "evidence_text": "Lifemel honey or regular honey"
    },
    {
      "element_type": "ResearchStudy",
      "code": "LA29458-3",
      "display": "Double-blind study",
      "system": "LOINC",
      "confidence_score": 1.0,
      "evidence_text": "double blind"
    },
    {
      "element_type": "LaboratoryResult",
      "code": "26464-8",
      "display": "Leukocytes [#/volume] in Blood",
      "system": "LOINC",
      "confidence_score": 1.0,
      "evidence_text": "WBC count"
    },
    {
      "element_type": "ResearchStudy",
      "code": "research-study",
      "display": "Clinical Trial",
      "system": "http://hl7.org/fhir/resource-types",
      "confidence_score": 1.0,
      "evidence_text": "briefTitle: Lifemel Honey to Reduce Leucopenia During Chemotherapy"
    },
    {
      "element_type": "ResearchStudy",
      "code": "research-study",
      "display": "Clinical Trial",
      "system": "http://hl7.org/fhir/resource-types",
      "confidence_score": 1.0,
      "evidence_text": "officialTitle: Lifemel Honey During Adjuvant Chemotherapy for Breast Cancer Patients to Prevent Leucopenia"
    },
    {
      "element_type": "ResearchStudy",
      "code": "NCT00243165",
      "display": "Clinical Trial Identifier",
      "system": "http://clinicaltrials.gov",
      "confidence_score": 1.0,
      "evidence_text": "nctId: NCT00243165"
    },
    {
      "element_type": "CancerCondition",
      "code": "C4878",
      "display": "Breast Cancer",
      "system": "http://ncimeta.nci.nih.gov",
      "confidence_score": 1.0,
      "evidence_text": "Breast Cancer Patients"
    },
    {
      "element_type": "CancerRelatedMedicationAdministration",
      "code": "C945",
      "display": "Chemotherapy",
      "system": "http://ncimeta.nci.nih.gov",
      "confidence_score": 1.0,
      "evidence_text": "Chemotherapy"
    },
    {
      "element_type": "CancerRelatedMedicationAdministration",
      "code": "C15262",
      "display": "Adjuvant Chemotherapy",
      "system": "http://ncimeta.nci.nih.gov",
      "confidence_score": 1.0,
      "evidence_text": "Adjuvant Chemotherapy"
    },
    {
      "element_type": "CancerRelatedMedicationAdministration",
      "code": "C15262",
      "display": "Adjuvant Chemotherapy",
      "system": "http://ncimeta.nci.nih.gov",
      "confidence_score": 1.0,
      "evidence_text": "During Adjuvant Chemotherapy"
    },
    {
      "element_type": "AdverseEvent",
      "code": "C3163",
      "display": "Leucopenia",
      "system": "http://ncimeta.nci.nih.gov",
      "confidence_score": 1.0,
      "evidence_text": "Leucopenia"
    },
    {
      "element_type": "AdverseEvent",
      "code": "C3163",
      "display": "Leucopenia",
      "system": "http://ncimeta.nci.nih.gov",
      "confidence_score": 1.0,
      "evidence_text": "to Reduce Leucopenia"
    },
    {
      "element_type": "AdverseEvent",
      "code": "C3163",
      "display": "Leucopenia",
      "system": "http://ncimeta.nci.nih.gov",
      "confidence_score": 1.0,
      "evidence_text": "to Prevent Leucopenia"
    }
  ]
}